Profile data is unavailable for this security.
About the company
GSK plc, formerly GlaxoSmithKline PLC is a global healthcare company. The Company is focused to improve the quality of human life by helping people. The Company operates through three core businesses: Pharmaceuticals, Vaccines and Consumer Healthcare. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency viruses (HIV), immuno-inflammation and oncology. It also focuses on immunology, human genetics, and advanced technologies to deliver transformational new medicines for patients. The Company's research and development focuses on developing vaccines against infectious diseases that combine high medical needs and market potential. The Company's Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands for oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, minerals and supplements. It provides prescription medicines, vaccines, and consumer healthcare products.
- Revenue in GBP (TTM)36.48bn
- Net income in GBP5.11bn
- LocationGSK plc980 Great West RoadBRENTFORD TW8 9GSUnited KingdomGBR
- Phone+44 208 047 5000
- Fax+44 208 047 7807
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|GSK:LSE since |
|Affinivax Inc||Announced||31 May 2022||31 May 2022Announced||3.33%||3.30bn|
|Sierra Oncology Inc||Announced||13 Apr 2022||13 Apr 2022Announced||0.10%||2.08bn|